Nutaria

Developer of targeted nanoparticle-based drug delivery therapies designed for brain disorders.

Health Tech & Life Sciences
Active
Pre-Seed Be'er Sheva, Israel Founded 2018
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2021-07
Stage
Pre-Seed
Founded
2018
Headcount
3
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences

About

Nutaria is a pioneering pharmaceutical R&D company focused on delivering novel solutions for neurodegenerative diseases through advanced drug development. The company's mission is to create innovative, targeted therapies that address the core challenges of brain disorders such as Parkinson's and Alzheimer's diseases. Nutaria utilizes advanced nanotechnology engineering methods to deliver antioxidants and protect the brain from aging, with a focus on developing high-quality active pharmaceutical ingredients (APIs) with precision delivery systems to improve efficacy and patient outcomes. Their revolutionary approach to targeted drug delivery aims to set a new standard in precision brain health interventions, delivering anti-inflammatory agents and therapeutic compounds directly to specific brain structures to enhance efficacy and reduce side effects.

Funding history · 1 round · — total

2021-06
Pre-Seed Undisclosed

Headcount over time

From 2 (2024-03) to 3 (2025-10) · +1 (+50%) · 4 points · source: Finder history + radar grounding
40 2024-03 2025-10

Q&A

What is Nutaria's primary focus?
Nutaria is a pharmaceutical R&D company focused on developing targeted nanoparticle-based drug delivery therapies for brain disorders, including neurodegenerative diseases like Parkinson's and Alzheimer's.
When was Nutaria founded?
Nutaria was founded in June 2018.
How much funding has Nutaria raised to date?
According to startupim data, Nutaria has raised a total of $300,000.
When did Nutaria complete its Pre-Seed funding round?
Nutaria completed a Pre-Seed funding round in July 2021, raising $300,000.
What is Nutaria's current product development stage?
Nutaria is currently in the advanced preclinical stages of developing a drug specifically for early Parkinson's disease.
Who is the CEO and Founder of Nutaria?
Omer Porat is the CEO and Founder of Nutaria.
What is Nutaria's approach to drug delivery?
Nutaria utilizes advanced nanotechnology engineering methods and a patented technology that uses food molecules as natural 'taxis' to deliver active ingredients directly to specific brain structures, aiming to improve efficacy and reduce side effects.

Team · 1

Omer Porat
Founder · CEO/Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

anti-agingdrug-deliveryalzheimers-diseasenatural-active-ingredientsnutraceuticalsbrain-disorderparkinsonpharmaceuticalssupplements
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitenutaria.com
LinkedInlinkedin.com/company/76074900

Identifiers & details

Founded2018-6
Employees (exact)3

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainnutaria.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515858041
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-06-11
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events1 — violation (1)
Registered addressהאנרגיה 77 באר שבע

Recent registry events

DateEvent
2026-05-27עדכון הפרה